Abstract
The aim of this study was to investigate the effect of the cyclo-oxygenase inhibitor ibuprofen on the acute-phase protein response and resting energy expenditure (REE) of weight-losing patients with pancreatic cancer. Patients with irresectable pancreatic cancer (n = 16) were treated with either ibuprofen (1200 mg day-1 for 7 days (n = 10) or placebo (n = 6). A group of 17 age-related non-cancer subjects were also studied. Indirect calorimetry, anthropometry, multifrequency bioelectrical impedence analysis and serum C-reactive protein (CRP) estimation were performed immediately before and after treatment. Before treatment, total REE was significantly elevated in the pancreatic cancer patients compared with healthy controls (1499 +/- 71 vs 1377 +/- 58 kcal) (P < 0.02). Following treatment the mean REE of the ibuprofen group fell significantly (1386 +/- 89 kcal) compared with pretreatment values (1468 +/- 99 kcal) (P < 0.02), whereas no change was observed in the placebo group. Serum CRP concentration was also reduced in the ibuprofen-treated group (pre-ibuprofen, 51 mg l-1; post-ibuprofen, 29 mg l-1; P < 0.05). These results suggest that ibuprofen may have a role in abrogating the catabolic processes which contribute to weight loss in patients with pancreatic cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wigmore, S., Falconer, J., Plester, C. et al. Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. Br J Cancer 72, 185–188 (1995). https://doi.org/10.1038/bjc.1995.300
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.300
This article is cited by
-
Beim Pankreaskarzinom gezielte Ernährung auf keinen Fall vernachlässigen
Gastro-News (2023)
-
Gezielte Ernährung beim Pankreaskarzinom — auf keinen Fall vernachlässigen!
InFo Hämatologie + Onkologie (2019)
-
Influence of an elevated nutrition risk score (NRS) on survival in patients following gastrectomy for gastric cancer
Medical Oncology (2015)
-
Cancer cachexia: impact, mechanisms and emerging treatments
Journal of Cachexia, Sarcopenia and Muscle (2013)
-
Management of paraneoplastic syndromes in lung cancer
Current Treatment Options in Oncology (2004)